atients with congestive heart failure (CHF) are frequently re-hospitalized, worsening their quality of life, and re-hospitalization for CHF is also associated with increased mortality rates. 1,2 Therefore, re-hospitalization for CHF should be avoided. Renal insufficiency increases the risk of CHF, [3] [4] [5] but most studies that have investigated the role of renal function in CHF have included only subjects with no known CHF or mild-to-moderate CHF and excluded patients with severe renal dysfunction. Patients hospitalized for CHF have more severe disease and impaired renal function, but little is known about the relation between renal dysfunction and re-hospitalization because of CHF. Thus, the aim of the present study was to investigate whether renal dysfunction is associated with rehospitalization for CHF after successful discharge.
a casual concentration ≥200 mg/dl, or a history of previous treatment. Dyslipidemia was defined as serum total cholesterol concentration ≥220 mg/dl, serum high-density lipoprotein-cholesterol concentration ≤40 mg/dl, serum triglyceride concentration ≥150 mg/dl, or previous treatment. 7 Anemia was defined as a serum hemoglobin concentration on admission <11 g/dl. 8, 9 Systolic dysfunction was defined as an ejection fraction on admission, estimated with echocardiography, of less than 50%. Worsening renal function during hospitalization was defined as serum creatinine concentra- Continuous variables are expressed as means ± SE and were compared by unpaired t-tests. Categorical variables are expressed as percentages and were compared by chi-square tests. Curves of cumulative rates of re-hospitalization-free survival were constructed with the Kaplan-Meier method and compared by the log-rank test. Univariate analysis or multivariate analysis for predictors of re-hospitalization was performed with the Cox proportional hazard test. Statistical significance was indicated by a p-value less than 0.05.
Results
The baseline characteristics of the patients are shown in Table 1 and Fig 1 shows the prevalence of renal dysfunction according to the chronic kidney disease stage. 11 Presence or absence of proteinuria was not considered. The estimated GFR was less than 60 ml·min -1 ·1.73 m -2 in 63% of patients. Fig 2 shows the re-hospitalization-free Kaplan-Meier curve for all patients. Patients with decreased renal function were more likely to be re-hospitalized (p<0.001, Fig 3) . The cutoff value of 45 ml· min -1 · 1.73 m -2 was determined by a receiver-operating characteristic curve for the ability of estimated GFR to detect CHF re-hospitalization at 1 year (Fig 3 inset) . The re-hospitalization-free rate at 1 year was 67.6% in patients with preserved renal function and 42.5% in patients with decreased renal function. Patients with decreased renal function were older and more likely to have anemia or to have previously been hospitalized because of CHF. Worsening renal function during hospitalization was more frequent in patients with decreased renal function ( Table 2 ). Worsening renal function was not related to intravenous use of loop diuretics, ANP, nitrates, or catecholamines (data not shown). Predictors of re-hospitalization because of CHF identified with univariate analysis were age, previous CHF hospitalization, absence of hypertension, presence of valvular heart disease, decreased renal function, and non-use of an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin-receptor blocker (ARB) ( Table 3 ). Background characteristics that differed significantly between the patients with decreased renal function and those with preserved renal function, and factors that were identified as predictors of re-hospitalization on univariate analysis were subjected to multivariate analysis, which revealed that independent predictors of re-hospitalization were previous hospitalization for CHF, age, non-use of ACEI/ARB, and decreased renal function (Table 4) .
Discussion

Relation Between Renal Dysfunction and CHF Re-Hospitalization
Our study found that renal dysfunction is an independent predictor of re-hospitalization for CHF. Several factors may be involved in the relationship between renal dysfunction and CHF. One is the renin -angiotensin system (RAS), which is activated in renal dysfunction, 12, 13 particularly by renal artery stenosis and renal ischemia. In renal dysfunction of any origin, the RAS is upregulated to maintain GFR through the compensatory mechanisms of increased glomerular capillary pressure and hyperfiltration. 13 Activation of the RAS exacerbates CHF, 13, 14 and inhibition of the RAS with an ACEI or ARB has been shown in many clinical trials to improve prognosis. Inhibition of the RAS also preserves renal function. However, ACEIs and ARBs are underused in patients who have CHF and renal dysfunction, 15, 16 probably because they can lead to hyperkalemia and elevated serum levels of creatinine. 17 In the present study, the rate of ACEI/ARB prescription did not different significantly between patients with preserved renal function and those with decreased renal function. In addition, non-use of ACEI/ARB and renal dysfunction were independently related to CHF re-hospitalization. However, we did not examine doses or serum concentrations of ACEIs and ARBs; underdosing of ACEIs and ARBs in patients with renal dysfunction might obscure the relationship between renal dysfunction and re-hospitalization for CHF.
Renal dysfunction activates the sympathetic nervous system (SNS), 18, 19 mainly because of renal ischemia. Decreased clearance of catecholamines is also involved. Angiotensin II can also stimulate the SNS. Inhibition of the SNS byblockers is a first-line therapy for patients with CHF and also has a beneficial effect on renal function. [18] [19] [20] In the present study, titration of -blockers to recommended dosage was not confirmed. Underuse of -blockers might explain why their non-use was not associated with re-hospitalization for CHF.
In an experimental model of CHF, sodium extrusion and natriuresis in response to volume expansion was intact and renal function was preserved, 21 suggesting that retention of both sodium and fluid is increased by renal dysfunction. Renal dysfunction induces anemia mainly because of impaired erythropoietin production. Anemia decreases oxygen delivery. Compensatory mechanisms, such as increased preload, reduced peripheral resistance, and increased cardiac output, exacerbate CHF. 22 Severe anemia also induces cardiac ischemia, even without severe coronary artery stenosis. 23 Although in the present study anemia was more frequent in patients with decreased renal function, it did not correlate with re-hospitalization for CHF. Recent studies found that anemia was not an important prognostic indicator after hospitalization for CHF in extremely elderly patients, 24 or in patients with preserved systolic function. 25 The effect of anemia might depend on the patient population. In patients with CHF sufficient diuresis sometimes worsens renal function, probably by decreasing renal perfusion. In such patients, diuretics are likely underused and patients are followed up under "wet" conditions. Patients in this condition cannot tolerate volume overload. CHF is exacerbated by ischemia; however, in patients with renal dysfunction, coronary angiography would be performed less often because of the risk of contrast nephropathy. Even when ischemia is detected with radioisotope scintigraphy, revascularization procedures are avoided for the same reason. Other mechanisms that might be involved in the relationship between decreased renal function and re-hospitalization for CHF include endothelin production, endothelial dysfunction, inflammation, oxidative stress, hypercoagulation 5, 12, 26 and other, as yet unidentified, mechanisms.
Other Factors Related to Re-Hospitalization for CHF
In the present study, previous hospitalization was the strongest predictor for re-hospitalization for CHF. Earlier studies have shown that previous hospitalization increases the rates of mortality and re-hospitalization for CHF. 27, 28 Hospitalization is required because of progression of CHF, but hospitalization might directly worsen prognosis because of the use of intravenous diuretics and catecholamines. 1 Deconditioning during hospitalization decreases exercise tolerance, which worsens prognosis and increases the likelihood of re-hospitalization. 29, 30 Hospitalization also worsens renal function. 31, 32 Some studies have reported that worsening renal function during hospitalization is related to CHF re- hospitalization, 10, 33 but the present study could not show statistical significance, possibly because of the small number of the samples and relatively small decrease in renal function. Preventing deterioration in renal function should be considered during hospitalization and after discharge. The present study also found that age was an independent predictor of re-hospitalization for CHF, probably because of comorbidity or associated deconditioning. Renal function decreases as age increases, 34 but in the present study age was a predictor independent of renal function. Elderly patients are at greater risk for infectious diseases, and infection exacerbates CHF. In addition, compliance with treatment is worse in elderly patients.
In contrast to previous studies, 35, 36 NYHA class was not associated with CHF re-hospitalization in the present study. Small sample size, and higher rate of elderly subjects in the present study might explain the difference. Estimation of NYHA class can be difficult in the elderly, partly because of a decrease in physical activity. In addition, NYHA class was estimated on the time of admission in the present study, so the NYHA class at discharge or during follow-up might be a better index.
Conclusion
Decreased renal function is an independent predictor of re-hospitalization for CHF. Even after successful discharge, careful follow-up care is needed, especially for patients with impaired renal function.
